6 studies found for:    weill | Open Studies | "Stomach Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
2 Recruiting Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma;   Gastric Cancer
Interventions: Drug: Docetaxel, Leucovorin, Fluorouracil, Cisplatin;   Drug: Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen
3 Recruiting Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma
Conditions: Gastric Adenocarcinoma;   Gastroesophageal Adenocarcinoma;   Distal Esophageal Adenocarcinoma
Intervention: Drug: Cabazitaxel
4 Unknown  Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Malignant Neoplasm of Cardio-esophageal Junction of Stomach
Interventions: Drug: Azacitidine;   Drug: Oxaliplatin;   Drug: Epirubicin;   Drug: Capecitabine
5 Recruiting Ph I Dose Escalation Study of Antibody-drug Conjugate IMMU-132 in Patients With Advanced Epithelial Cancers
Conditions: Advanced Epithelial Cancers;   Ovarian Cancer;   Prostate Cancer;   Lung Cancer;   Breast Cancer;   Gastric Cancer;   Colorectal Cancer;   Pancreatic Cancer;   Hepatocellular Cancer
Intervention: Drug: IMMU-132
6 Recruiting Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma
Condition: Gastric Cancer
Interventions: Procedure: Roux-en-Y pouch reconstruction (RYP);   Procedure: conventional Roux-en-Y reconstruction (RYC)

Indicates status has not been verified in more than two years